PMID: 8938276Dec 1, 1995Paper

Selection of potent immunological adjuvants for vaccine construction

Seminars in Cancer Biology
M J McElrath

Abstract

With the recent development of recombinant protein and peptide immunogens, the need to improve immunogenicity has renewed interest in adjuvants. Several new adjuvants and vehicles reported to augment immunity to experimental vaccines in animal models are currently under evaluation in phase I and II clinical trials. Overall these formulations appear safe and several experimental adjuvants may be superior to alum, the only licensed adjuvant. These studies lend encouragement toward this approach to elicit and boost immunity against cancers and infectious pathogens, and indicate the need for additional large comparative adjuvant trials to advance the adjuvant trials to advance the adjuvant field.

References

Jan 1, 1992·Vaccine·A W Heath, J H Playfair
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L F FriesC R Alving
Feb 1, 1991·The Journal of Infectious Diseases·J WintschJ M Dayer
Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M GirardE Muchmore
Jan 1, 1990·International Reviews of Immunology·R Edelman, C O Tacket
Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J A QuirogaA Mora
Mar 1, 1990·Immunology Today·G Gregoriadis
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R C DesrosiersM D Daniel
Apr 1, 1985·European Journal of Biochemistry·C GalanosH Yoshimura
Nov 15, 1974·Nature·A G Allison, G Gregoriadis
Aug 19, 1974·Biochemical and Biophysical Research Communications·F EllouzE Lederer
Feb 1, 1995·AIDS Research and Human Retroviruses·M F PowellM J Newman
Jan 1, 1993·Vaccine·R K GuptaC K Gupta
Oct 1, 1955·Proceedings of the Society for Experimental Biology and Medicine·M LANDY, A G JOHNSON

❮ Previous
Next ❯

Citations

Jul 28, 2005·Cancer Immunology, Immunotherapy : CII·Deborah J MarshallLinda A Snyder
Jun 28, 2008·Cancer Immunology, Immunotherapy : CII·Ilham BettahiLbachir BenMohamed
May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
Mar 5, 2003·Vaccine·Tosca G M LauterslagerLuuk A T Hilgers
Nov 20, 2003·Methods : a Companion to Methods in Enzymology·Michele T PritchardElizabeth A Repasky
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M R Hilleman
Oct 31, 2002·Seminars in Oncology·Boris R Minev
Oct 14, 2004·Immunology and Cell Biology·Nikolai Petrovsky, Julio César Aguilar
Oct 11, 2012·Genetic Vaccines and Therapy·Sarfraz AhmadMark Tangney
Feb 27, 2007·Journal of Zhejiang University. Science. B·Zahid Iqbal RajputAbdullah G Arijo
Jun 2, 2007·Journal of Zhejiang University. Science. B·Zahid Iqbal RajputNoor Mohammad Soomro
Apr 6, 1999·Pharmacology & Therapeutics·B R MinevM S Mitchell
Sep 6, 2006·Journal of Liposome Research·Carl R Alving
Aug 10, 2012·Expert Review of Vaccines·Carl R AlvingAlexander V Mayorov
Aug 29, 2014·Expert Review of Vaccines·Robert J O'ConnellJean-Louis Excler
Nov 4, 2000·Expert Opinion on Investigational Drugs·M L Salgaller
Feb 11, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Akhilesh Kumar ShakyaHarvinder Singh Gill
May 30, 2013·Journal of Ginseng Research·Soowon Kang, Hyeyoung Min
Sep 6, 2011·Drug Discovery Today·Chintan ChhatbarSunit Kumar Singh
Aug 10, 2010·International Journal of Pharmaceutics·Zhenghua ZhongLijuan Chen
May 6, 2008·Vaccine·Nicholas J SteersMangala Rao
Jan 30, 2008·Vaccine·Carl R Alving, Mangala Rao
Jun 24, 2015·Vaccine·Jean-Louis ExclerJerome H Kim
Aug 8, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Alexis García, Juan B De Sanctis
Jan 10, 2004·The Journal of Urology·Kent G KrejciEugene D Kwon
Nov 23, 2015·American Journal of Preventive Medicine·Jean-Louis ExclerJerome H Kim
Dec 20, 2002·Clinics in Laboratory Medicine·Marnie L Elizaga, M Juliana McElrath
Oct 30, 2010·Immunity·M Juliana McElrath, Barton F Haynes
Jun 9, 2016·Current Opinion in Immunology·Kathryn E StephensonDan H Barouch
Sep 17, 2016·Human Vaccines & Immunotherapeutics·Nathalie Garçon, Alberta Di Pasquale
Feb 13, 2016·Expert Opinion on Drug Delivery·Carl R AlvingMangala Rao
Jun 13, 2018·The Journal of Infectious Diseases·Mangala RaoCarl R Alving
Jun 13, 2014·Clinical and Vaccine Immunology : CVI·Jean-Louis ExclerStanley A Plotkin
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R S Chamberlain, H Kaufman
Apr 2, 2020·Expert Review of Vaccines·Carl R AlvingZoltan Beck
Feb 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·F HladikM J McElrath
Dec 27, 2016·Frontiers in Immunology·Shailendra Kumar Verma, Urmil Tuteja
Jun 12, 1998·Journal of Surgical Oncology·M L Salgaller, P A Lodge
Jun 22, 2021·Expert Opinion on Drug Delivery·Pedro Gonzalez-Cruz, Harvinder Singh Gill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Chemical & Pharmaceutical Bulletin
Noriaki FukuyamaYutaka Orihara
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Zhijun SongNiels Høiby
Immunology and Cell Biology
Georg BehrensWilliam R Heath
© 2021 Meta ULC. All rights reserved